Only two studies have investigated the distribution of KIR and HLA genes in CRC specimens [36]; [37], but these studies analyzed only KIR/HLA frequencies in cancer patients compared to normal control subjects with the aim to test the impact of KIR/HLA status on individual’s susceptibility to CRC. The gene discussed is KIR3DL1; the disease is colorectal carcinoma.